Data / Drug companies / Acetazolamide
Acetazolamide: 37 companies and 69 products in the FDA NDC directory
Acetazolamide is listed in the FDA National Drug Code Directory by 37 companies, with 69 products in commercial distribution. 69 of the products (100.0%) are marketed under an abbreviated new drug application (ANDA), the generic route. The most common dosage forms are tablet; capsule, extended release; injection, powder, lyophilized, for solution, and the newest product started marketing on April 28, 2026.
SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.
- Companies listing it
- 37
- Products
- 69
- Generic (ANDA) products
- 69 (100.0%)
- Application numbers
- 21
- Routes
- Oral, Intravenous
- openFDA record search
- api.fda.gov
Companies that list acetazolamide
Ranked by number of products. Finished drugs in commercial distribution.
| Company | Products | Main dosage forms | Main marketing category | Newest product started |
|---|---|---|---|---|
| Heritage Pharmaceuticals Inc. D/B/A Avet Pharmaceuticals Inc. | 5 | tablet; injection, powder, lyophilized, for solution | Generic drugs (ANDA) | November 15, 2022 |
| A-S Medication Solutions | 4 | tablet; capsule, extended release | Generic drugs (ANDA) | July 15, 2023 |
| Chartwell RX, LLC | 3 | tablet; capsule, extended release | Generic drugs (ANDA) | February 15, 2021 |
| NuCare Pharmaceuticals,Inc. | 3 | tablet | Generic drugs (ANDA) | July 15, 2023 |
| PD-Rx Pharmaceuticals, Inc. | 3 | tablet | Generic drugs (ANDA) | January 30, 2020 |
| Zydus Pharmaceuticals USA Inc. | 3 | tablet; capsule | Generic drugs (ANDA) | August 4, 2023 |
| Aarkish Pharmaceuticals NJ Inc. | 2 | tablet | Generic drugs (ANDA) | December 3, 2024 |
| Advagen Pharma Ltd | 2 | tablet | Generic drugs (ANDA) | August 19, 2021 |
| Ajanta Pharma USA Inc. | 2 | tablet | Generic drugs (ANDA) | September 11, 2023 |
| Ani Pharmaceuticals, Inc. | 2 | tablet | Generic drugs (ANDA) | October 17, 2019 |
| Aurobindo Pharma Limited | 2 | tablet | Generic drugs (ANDA) | May 30, 2025 |
| AvKARE | 2 | tablet | Generic drugs (ANDA) | May 18, 2017 |
| Bryant Ranch Prepack | 2 | tablet | Generic drugs (ANDA) | November 13, 2020 |
| Bryant Ranch Prepack | 2 | tablet | Generic drugs (ANDA) | November 13, 2020 |
| Bryant Ranch Prepack | 2 | tablet; capsule, extended release | Generic drugs (ANDA) | November 19, 2021 |
| Eywa Pharma Inc | 2 | tablet | Generic drugs (ANDA) | January 30, 2020 |
| Hikma Pharmaceuticals USA Inc. | 2 | injection, powder, lyophilized, for solution | Generic drugs (ANDA) | May 1, 1996 |
| Lifestar Pharma LLC | 2 | tablet | Generic drugs (ANDA) | November 13, 2020 |
| Marlex Pharmaceuticals, Inc. | 2 | tablet | Generic drugs (ANDA) | February 1, 2026 |
| Strides Pharma Science Limited | 2 | tablet | Generic drugs (ANDA) | November 20, 2017 |
| TruPharma, LLC | 2 | tablet | Generic drugs (ANDA) | April 19, 2021 |
| Viona Pharmaceuticals Inc | 2 | tablet | Generic drugs (ANDA) | July 15, 2023 |
| Zydus Lifesciences Limited | 2 | tablet | Generic drugs (ANDA) | July 15, 2023 |
| Accord Healthcare Inc. | 1 | capsule, extended release | Generic drugs (ANDA) | November 19, 2021 |
| Alembic Pharmaceuticals Inc. | 1 | capsule, extended release | Generic drugs (ANDA) | February 20, 2019 |
| Alembic Pharmaceuticals Limited | 1 | capsule, extended release | Generic drugs (ANDA) | February 20, 2019 |
| American Health Packaging | 1 | capsule | Generic drugs (ANDA) | October 27, 2020 |
| AvPAK | 1 | tablet | Generic drugs (ANDA) | July 7, 2020 |
| Gland Pharma Limited | 1 | injection, powder, lyophilized, for solution | Generic drugs (ANDA) | June 17, 2025 |
| Ingenus Pharmaceuticals, LLC | 1 | capsule, extended release | Generic drugs (ANDA) | July 31, 2017 |
| Major Pharmaceuticals | 1 | tablet | Generic drugs (ANDA) | March 15, 2013 |
| Northwind Health Company, LLC | 1 | tablet | Generic drugs (ANDA) | March 28, 2023 |
| Proficient Rx LP | 1 | tablet | Generic drugs (ANDA) | November 21, 2017 |
| Remedyrepack Inc. | 1 | capsule, extended release | Generic drugs (ANDA) | April 28, 2026 |
| Westminster Pharmaceuticals, LLC | 1 | capsule, extended release | Generic drugs (ANDA) | April 20, 2023 |
| XGen Pharmaceuticals DJB, Inc. | 1 | injection, powder, lyophilized, for solution | Generic drugs (ANDA) | December 10, 2008 |
| Zydus Lifesciences Limited | 1 | capsule | Generic drugs (ANDA) | April 10, 2019 |
Dosage forms
| Dosage form | Products | Share |
|---|---|---|
| Tablet | 50 | 72.5% |
| Capsule, extended release | 10 | 14.5% |
| Injection, powder, lyophilized, for solution | 6 | 8.7% |
| Capsule | 3 | 4.3% |
Marketing categories
| Marketing category | Products | Share |
|---|---|---|
| Generic drugs (ANDA) | 69 | 100% |
Pharmacologic classes
| Class | Products |
|---|---|
| Carbonic Anhydrase Inhibitor | 69 |
Updated November 6, 2026. Read from US Food and Drug Administration, National Drug Code Directory (openFDA). CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.